For exclusive news and updates, subscribe to our Survivor Newsletter: It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted ...
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), with a price target of $76.00. The company’s shares ...
The company didn’t respond to requests for comment. Donald Trump speaking at a December news conference, accompanied by Cantor Fitzgerald CEO Howard Lutnick and SoftBank CEO Masayoshi Son.